Evidence map›Paper›PMID 30180881›Full record

ArticleBreast cancer research : BCR2018

NOTCH3 expression is linked to breast cancer seeding and distant metastasis.

Alexey A Leontovich, Mohammad Jalalirad, Jeffrey L Salisbury, Lisa Mills, Candace Haddox, Mark Schroeder, Ann Tuma, Maria E Guicciardi, Luca Zammataro, Mario W Gambino and 13 more

Open access · goldAbstract read
In one paragraph

Article in Breast cancer research : BCR, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 1 synthesis or guideline pooled it, 83 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Biological profile of breast cancer brain metastasis.Acta neuropathologica communications · 2025
    Review
  9. Article
  10. Review
  11. Review
  12. Frontiers in pharmacology · 2025
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 5 institutions in 2 countries.

Alexey A LeontovichDepartment of Biomedical Statistics and Informatics, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN, USA.
Mohammad JalaliradDepartment of Medical Oncology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN, USA.
Jeffrey L SalisburyDepartment of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN, USA.
Lisa MillsDepartment of Molecular Medicine, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN, USA.
Candace HaddoxDepartment of Medical Oncology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN, USA.
Mark SchroederDepartment of Medical Oncology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN, USA.
Ann TumaDepartment of Medical Oncology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN, USA.
Maria E GuicciardiDepartment of Internal Medicine, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN, USA.
Luca ZammataroDepartment of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA.
Mario W GambinoDepartment of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN, USA.
Angela AmatoDepartment of Cellular and Developmental Biology, University of Palermo, Palermo, Italy.
Aldo Di LeonardoDepartment of Cellular and Developmental Biology, University of Palermo, Palermo, Italy.
James McCubreyDepartment of Microbiology and Immunology, Brody School of Medicine, East Carolina University, Greenville, NC, USA.
Carol A LangeDepartment of Medicine and Pharmacology, University of Minnesota, Minneapolis, MN, USA.
Minetta LiuDepartment of Medical Oncology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN, USA.
Tufia HaddadDepartment of Medical Oncology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN, USA.
Matthew GoetzDepartment of Medical Oncology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN, USA.
Judy BougheyDepartment of Surgery, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN, USA.
Jann SarkariaDepartment of Medical Oncology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN, USA.
Liewei WangDepartment of Medical Oncology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN, USA.
James N IngleDepartment of Medical Oncology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN, USA.
Evanthia GalanisDepartment of Medical Oncology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN, USA.
Antonino B D'AssoroDepartment of Medical Oncology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN, USA. dassoro.antonio@mayo.edu.ORCID 0000-0003-4436-4634
Mayo Clinic · USUniversity of Palermo · ITEast Carolina University · USUniversity of Minnesota · USYale University · US

Funding

The Role of CHFR in Tumorigenesis and Paclitaxel-Sensitivity in Breast CancerP50CA116201 · NCI · MAYO CLINIC ROCHESTER · PI PETER C LUCAS · 2005 to 2026
$49.9M
CENTROSOME HYPERTROPHY IN HUMAN BREAST TUMORSR01CA072836 · NCI · MAYO CLINIC ROCHESTER · PI SALISBURY, JEFFREY L · 1998 to 2006
$1.9M
Targeting Aurora-A Kinase to Overcome Endocrine Resistance in ER+ Breast CancerR01CA214893 · NCI · MAYO CLINIC ROCHESTER · PI D'ASSORO, ANTONIO BONAVENTURA, HADDAD, TUFIA C · 2017 to 2021
$1.6M
NCI NIH HHS P50 CA116201NCI NIH HHS R01 CA072836NCI NIH HHS R01 CA214893
6 · The paper itself

Abstract

backgroundDevelopment of distant metastases involves a complex multistep biological process termed the invasion-metastasis cascade, which includes dissemination of cancer cells from the primary tumor to secondary organs. NOTCH developmental signaling plays a critical role in promoting epithelial-to-mesenchymal transition, tumor stemness, and metastasis. Although all four NOTCH receptors show oncogenic properties, the unique role of each of these receptors in the sequential stepwise events that typify the invasion-metastasis cascade remains elusive.

methodsWe have established metastatic xenografts expressing high endogenous levels of NOTCH3 using estrogen receptor alpha-positive (ERα

resultsIn this study, we identified an association between NOTCH3 expression and development of metastases in ERα

conclusionsThese findings demonstrate the key role of NOTCH3 oncogenic signaling in the genesis of breast cancer metastasis and provide a compelling preclinical rationale for the design of novel therapeutic strategies that will selectively target NOTCH3 to halt metastatic seeding and to improve the clinical outcomes of patients with breast cancer.

Indexed as

Gene Expression ProfilingGene Expression Regulation, NeoplasticAnimalsBreast NeoplasmsCell Line, TumorCell Self RenewalFemaleHumansMCF-7 CellsMice, NudeMiddle AgedNeoplasm SeedingReceptor, Notch3RNA InterferenceSurvival AnalysisTransplantation, HeterologousReceptor, Notch3Breast cancerCentrosome amplificationChromosomal instabilityMetastasisTumor stemness

Identifiers

PMID30180881
PMCPMC6123953
OpenAlexW2891778293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.